Trump DOJ Seeks Dismissal of Mifepristone Lawsuit

The Trump administration's Department of Justice has moved to dismiss a lawsuit from Missouri, Idaho, and Kansas that seeks to restrict access to the abortion pill mifepristone by challenging FDA regulations. The DOJ's filing argues that the states lack standing, Texas is not the proper venue, and highlights issues like statute of limitations and lack of actual harm from FDA rules. The administration did not address the merits of mifepristone's approval, focusing instead on procedural grounds and executive authority. This stance aligns with their continuation of the Biden administration's legal approach, despite the Trump administration's generally anti-abortion platform. Trump has stated he does not intend to restrict mifepristone at the federal level, leaving decisions to individual states, a position that has frustrated some anti-abortion groups. Legal experts suggest the DOJ's procedural defense aims to preserve precedent in regulatory challenges from both Republican- and Democratic-led states.